Stock PARABDRUGS PARABOLIC DRUGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Parabolic Drugs Limited NSE India S.E.

Equities

PARABDRUGS

INE618H01016

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended 31 December, 2020
CI
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Quarter and Half Year Ended September 30, 2020
CI
Parabolic Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019
CI
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended March 31, 2020
CI
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Quarter Ended September 30, 2018
CI
Parabolic Extends Submission Date For EOI’s
CI
Parabolic Drugs Limited Reports Unaudited Earnings Results for the Second Quarter and Half Year Ended September 30, 2018
CI
Parabolic Drugs Limited Announces Unaudited Earnings Results for the Quarter Ended June 30, 2018
CI
Parabolic Drugs Limited Announces Change of Registered/Corporate Office
CI
Parabolic Drugs Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2018
CI
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
CI
Parabolic Drugs Limited Announces Executive Changes
CI
Parabolic Drugs Limited Announces Executive Changes
CI
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017
CI
Parabolic Drugs Ltd. Announces Unaudited Earnings Results for First Quarter Ended June 30, 2017
CI
Parabolic Drugs Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2017
CI
Parabolic Drugs Ltd Appoints Ashok Kumar Jindal as CFO
CI
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016
CI
Parabolic Drugs Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2016
CI
Parabolic Drugs Limited Announces Resignation of Sandeep Sharma as Chief Financial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PARABDRUGS Stock
  4. PARABDRUGS Stock
  5. News Parabolic Drugs Limited